Arkema S.A. (EPA:AKE)
France · Delayed Price · Currency is EUR | Market Cap | 4.20B +2.4% |
| Revenue (ttm) | 8.90B -5.7% |
| Net Income | 18.50M -73.7% |
| EPS | 0.24 -90.1% |
| Shares Out | 75.61M |
| PE Ratio | 231.65 |
| Forward PE | 11.39 |
| Dividend | 3.60 (6.49%) |
| Ex-Dividend Date | May 25, 2026 |
| Volume | 278,874 |
| Open | 56.15 |
| Previous Close | 55.75 |
| Day's Range | 55.50 - 56.55 |
| 52-Week Range | 48.30 - 67.05 |
| Beta | 0.96 |
| Analysts | Hold |
| Price Target | 62.93 (+13.39%) |
| Earnings Date | Nov 5, 2026 |
About Arkema
Arkema S.A., together with its subsidiaries, manufactures and sells specialty materials in Europe, the United States, Canada, Mexico, China, Hong Kong, Taiwan, and internationally. It operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The company provides solutions for construction, renovation of buildings, and DIY; high performance adhesives for durable goods, and adhesive solutions for packaging and non-woven; and supplies technologies used in building activities for businesses and ind... [Read more]
Financial Performance
In 2025, Arkema's revenue was 9.07 billion, a decrease of -4.99% compared to the previous year's 9.54 billion. Earnings were 39.00 million, a decrease of -88.46%.
Financial StatementsAnalyst Summary
According to 14 analysts, the average rating for AKE stock is "Hold." The 12-month stock price target is €62.93, which is an increase of 13.39% from the latest price.
News
François Desné Appointed Arkema's Senior Vice President High Performance Polymers and Fluorogases and Member of the Executive Committee
PARIS LA DÉFENSE--(BUSINESS WIRE)--Regulatory News: François Desné joins Arkema (Paris:AKE) as Senior Vice President High Performance Polymers and Fluorogases and a member of the Group's Executive Com...
Arkema Slides: Investor presentation
Arkema has posted slides in relation to its latest quarterly earnings report, which was published on September 1, 2026.
Arkema upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Katie Richards upgraded Arkema (ARKAY) to Equal Weight from Underweight with a price target of EUR 56, up from EUR 51. The firm says Q2 “marked a clear…
Arkema Earnings Call Transcript: Q2 2026
Q2 2026 saw EBITDA rise 7% year-on-year to €391 million, driven by strong adhesives and coatings, despite weak demand in Europe and the U.S. and ongoing Middle East disruptions. Guidance for slight EBITDA growth in 2026 is confirmed, with major projects contributing to future earnings.
Arkema Earnings release: Q2 2026
Arkema released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Arkema Slides: Q2 2026
Arkema has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
Arkema Quarterly report: Q2 2026
Arkema has published its Q2 2026 quarterly earnings report on July 30, 2026.
Arkema downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Lisa De Neve downgraded Arkema (ARKAY) to Equal Weight from Overweight with a price target of EUR 63, down from EUR 83. The firm sees a lack…
Arkema price target raised to EUR 55 from EUR 52 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Arkema (ARKAY) to EUR 55 from EUR 52 and keeps a Hold rating on the shares.
Arkema price target raised to EUR 55 from EUR 52 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Arkema (ARKAY) to EUR 55 from EUR 52 and keeps a Hold rating on the shares.
Arkema downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Georgina Fraser downgraded Arkema (ARKAY) to Neutral from Buy with a price target of EUR 63, down from EUR 67. The firm made seven rating changes in…
Arkema downgraded to Underweight from Neutral at JPMorgan
JPMorgan downgraded Arkema (ARKAY) to Underweight from Neutral with a EUR 10 price target as part of a broader sector note on European Chemicals. Mid-term earnings and ROIC outlook remains…
Arkema Slides: FY 2026
Arkema has posted slides in relation to its FY 2026 quarterly earnings report, which was published on May 21, 2026.
Arkema downgraded to Reduce from Hold at Kepler Cheuvreux
Kepler Cheuvreux analyst Martin Roediger downgraded Arkema (ARKAY) to Reduce from Hold with a EUR 60 price target
Arkema Earnings Call Transcript: Q1 2026
Q1 2026 delivered stable volumes and strong Specialty Materials growth, offset by currency headwinds and weak U.S./Europe demand. EBITDA rose 14% sequentially but fell year-on-year; price increases and major projects are set to support Q2 and full-year guidance.
Arkema Earnings release: Q1 2026
Arkema released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Arkema Slides: Q1 2026
Arkema has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Arkema downgraded to Hold from Buy at Berenberg
Berenberg analyst Sebastian Bray downgraded Arkema (ARKAY) to Hold from Buy with an unchanged price target of EUR 62. The firm cites valuation for the downgrade with the shares reaching…
Arkema upgraded to Market Perform from Underperform at Bernstein
Bernstein upgraded Arkema (ARKAY) to Market Perform from Underperform with a price target of EUR 64, up from EUR 54. The firm says the company has reached the end of…
Arkema price target raised to EUR 50 from EUR 49 at Deutsche Bank
Deutsche Bank analyst Virginie Boucher-Ferte raised the firm’s price target on Arkema (ARKAY) to EUR 50 from EUR 49 and keeps a Hold rating on the shares. Published first on…
Arkema price target raised to EUR 83 from EUR 78 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Arkema (ARKAY) to EUR 83 from EUR 78 and keeps an Overweight rating on the shares.
Arkema price target raised to EUR 62 from EUR 60 at Berenberg
Berenberg raised the firm’s price target on Arkema (ARKAY) to EUR 62 from EUR 60 and keeps a Buy rating on the shares.
Arkema downgraded to Hold from Buy at Kepler Cheuvreux
Kepler Cheuvreux downgraded Arkema (ARKAY) to Hold from Buy with a EUR 65 price target
Arkema Earnings Call Transcript: Q4 2025
2025 saw challenging macro conditions with weak demand in Europe and the U.S., but strong growth in Asia. EBITDA fell to EUR 1.25 billion, but cash generation and cost control exceeded targets. 2026 guidance is for slight EBITDA growth at constant FX, with major projects and a new segment structure supporting future performance.